---
document_datetime: 2023-09-21 21:30:48
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rinvoq-epar-all-authorised-presentations_en.pdf
document_name: rinvoq-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4411486
conversion_datetime: 2025-12-19 00:42:06.322789
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging        | Pack size                       |
|------------------|-------------------|------------|--------------------------|---------------------------|----------------------------|---------------------------------|
| EU/1/19/1404/001 | Rinvoq            | 15 mg      | Prolonged-release tablet | Oral use                  | blister (PVC/PE/PCTFE/alu) | 28 tablets                      |
| EU/1/19/1404/002 | Rinvoq            | 15 mg      | Prolonged-release tablet | Oral use                  | bottle (HDPE)              | 30 tablets                      |
| EU/1/19/1404/003 | Rinvoq            | 15 mg      | Prolonged-release tablet | Oral use                  | blister (PVC/PE/PCTFE/alu) | 84 (3 x 28) tablets (multipack) |
| EU/1/19/1404/004 | Rinvoq            | 15 mg      | Prolonged-release tablet | Oral use                  | bottle (HDPE)              | 90 (3 x 30) tablets             |
| EU/1/19/1404/005 | Rinvoq            | 15 mg      | Prolonged-release tablet | Oral use                  | blister (PVC/PE/PCTFE/alu) | 98 tablets                      |
| EU/1/19/1404/006 | Rinvoq            | 30 mg      | Prolonged-release tablet | Oral use                  | blister (PVC/PE/PCTFE/alu) | 28 tablets                      |
| EU/1/19/1404/007 | Rinvoq            | 30 mg      | Prolonged-release tablet | Oral use                  | bottle (HDPE)              | 30 tablets                      |
| EU/1/19/1404/008 | Rinvoq            | 30 mg      | Prolonged-release tablet | Oral use                  | bottle (HDPE)              | 90 (3 x 30) tablets             |
| EU/1/19/1404/009 | Rinvoq            | 30 mg      | Prolonged-release tablet | Oral use                  | blister (PVC/PE/PCTFE/alu) | 98 tablets                      |
| EU/1/19/1404/010 | Rinvoq            | 45 mg      | Prolonged-release tablet | Oral use                  | blister (PVC/PE/PCTFE/alu) | 28 tablets                      |
| EU/1/19/1404/011 | Rinvoq            | 45 mg      | Prolonged-release tablet | Oral use                  | bottle (HDPE)              | 28 tablets                      |